This book provides a detailed description of all assessment scales used for the evaluation of drugs within the framework of psychiatry. It compares their relative merits and presents a procedure for making optimal choices for use in clinical experiments. Moreover, it discusses protocol design and quality control of clinical trials. Psychiatrist-, nurse- and self-assessment scales for studies in anxiety, depression, schizophrenia, mania and dementia are fully described. Comparative Evaluation of Rating Scales in Clinical Psychopharmacology is aimed at all those in industry, university, private hospital and/or private practice who concern themselves with clinical trials of psychoactive drugs.
This book provides a detailed description of all assessment scales used for the evaluation of drugs within the framework of psychiatry. It compares their relative merits and presents a procedure for making optimal choices for use in clinical experiments. Moreover, it discusses protocol design and quality control of clinical trials. Psychiatrist-, nurse- and self-assessment scales for studies in anxiety, depression, schizophrenia, mania and dementia are fully described. Comparative Evaluation of Rating Scales in Clinical Psychopharmacology is aimed at all those in industry, university, private hospital and/or private practice who concern themselves with clinical trials of psychoactive drugs.
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Technology
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Maße
Höhe: 230 mm
Breite: 150 mm
Gewicht
ISBN-13
978-0-444-80896-7 (9780444808967)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Part A - Rating Scales as Instruments for the Evaluation of Psychiatric Patients. Section I. Introduction. Section II. Method of evaluation and comparison of rating scales. Part B. General Purpose Rating Scales. Section III. Description of general purpose rating scales. Section IV. Discussion of the results of rating general purpose rating scales. Part C. Scales Used for Research in Depression. Section V. Introduction to the evaluation of depression. Section VI. Description of rating scales for the evaluation of depression. Section VII. Discussion of the results of the comparative evaluation of depression scales and recommendation. Part D. Scales used for Evaluation of Anxiety and Phobic and Obsessional Disorders. Section VIII. Introduction to the evaluation of anxiety and related disorders. Section IX. Description of rating scales for the evaluation of anxiety and of phobic and obsessional disorders. Section X. Discussion of the results of scales for the evaluation of anxiety and of phobic and obsessional disorders and recommendations. Part E. Scales Used for Evaluation of Psychotic Behaviour. Section XI. Introduction to the evaluation of schizophrenic and manic states. Section XII. Description of the rating scales for the assessment of schizophrenic and manic disorders. Section XIII. Discussion of the results of the comparative evaluation of scales for the assessment of psychotic behaviour and recommendations. Part F. Scales for Evaluation in Geriatric Patients. Section XIV. Introduction. Section XV. Description of geriatric rating scales. Section XVI. Comparative evaluation of geriatric rating scales and recommendations. Part G. Clinical Trial Design. Section XVII. Towards an integral psychopharmacological evaluation system. Section XVIII. Design of drug trials in psychiatry. Section XIX. Quality Control. Section XX. Concluding remarks: scales, drugs and people.